Overview

The Efficacy of Stabilized Chlorine Dioxide Rinse as a Chemical Adjuvant for Treatment of Per-implant Mucositis

Status:
Completed
Trial end date:
2020-03-04
Target enrollment:
Participant gender:
Summary
A full understanding of etiology and diagnosis of peri-implant diseases is crucial for finding effective treatments for these diseases that are more widely accessible to dentists. Several treatment protocols for peri-implant diseases have been proposed, but no gold standard has been established to date. Thus, the purpose of this study is to analyze efficacy of stabilized chlorine dioxide as a chemical adjuvant for treatment of peri-implant mucositis in a non-surgical treatment protocol with a 3-month follow-up.
Phase:
Phase 4
Details
Lead Sponsor:
Rowpar Pharmaceuticals, Inc.
Collaborator:
Stony Brook University
Treatments:
Chlorine dioxide